Clinical Trial Update: Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the safety of adjunct brexpiprazole in elderly patients with major depressive disorder who had an inadequate response to antidep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Rexulti (brexpiprazole) (brexpiprazole)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depression Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-06-26